The FDA approved safety labeling revisions for rosiglitazone maleate plus glimepiride tablets (Avandaryl, made by GlaxoSmithKline) to warn of the increased risk for rosiglitazone-related cardiovascular (CV) events in patients with New York Heart Association (NYHA) class 1 and 2 cardiac status.
Read More »Diabetes In Control
U.S. Health-Care System Scores a D for Quality
The US, which spends more then twice the average of other countries received a score of 66 out of 100. The US ranked below Iceland, France, Japan, Italy, Sweden and many others, especially in controlling high blood pressure and diabetes. Compared with other countries, the United States is ranked near …
Read More »Effects of Duration of Type 2 Diabetes on Insulin Secretion
The effectiveness of therapies designed to preserve or increase beta cell function varies from one patient to another
Read More »Study Shows Leptin Combats Type 2 Diabetes
University of Florida researchers have discovered the appetite-controlling hormone leptin could also combat type 2 diabetes as more Americans pack on extra pounds.
Read More »Ibuprofen Reduces Protective Effects of Aspirin
The US Food and Drug Administration (FDA) has notified healthcare professionals and consumers that taking ibuprofen for pain relief may interfere with the benefits of aspirin taken for heart disease.
Read More »Analysis of 6 Studies Shows Aspirin Can Reduce the Risk for Coronary Heart Disea
Even with the positive results from all of the studies with over 100,000 patients, most patients with Type 2 diabetes are not taking aspirin!
Read More »Don’t Supersize: NIH Study Shows Eating French Fries Increases Risk for Diabetes
84,555 registered female nurses were followed up for 20 years and they found that eating potatoes, especially french fries, is associated with an increased risk of developing Type 2 diabetes. See McDonald’s answer to the results.
Read More »Rosiglitazone Reduces Microalbuminuria and BP Independently of Glycemia
Rosiglitazone added to background therapy with metformin provides greater reductions in microalbuminuria and blood pressure as compared with glyburide.
Read More »Diabetes Will Cripple Health Budgets
The growing diabetes epidemic could cripple healthcare budgets in coming decades, particularly in eastern countries.
Read More »India Faces Diabetes Crisis
A surge in diabetes cases in India threatens the whole health care system. The cost for the increase in diabetes is estimated to be over 250 billion dollars.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.